Thank you for joining us for Spire's year-end fiscal 2025 update. This includes the pending acquisition of the Piedmont ...
Here is how Alto Neuroscience, Inc. (ANRO) and Editas Medicine (EDIT) have performed compared to their sector so far this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback